IP31-22: Clinical utility and prognostic value of a six-gene signature for aggressive prostate cancer among clinically low risk patients
Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
145AB
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!